Authors
Ayelet Goldstein, Carlos Fresno Cañada, Joan Gispets
Published in
Translational vision science & technology. Volume 15. Issue 11. Pages 18. Nov 02, 2026.
Abstract
To evaluate whether macular optical coherence tomography (OCT) distinguishes eyes with versus without recorded magnetic resonance imaging (MRI)-defined eye-level optic pathway glioma (OPG) status in neurofibromatosis type 1, and whether longitudinal OCT, visual/clinical variables, optic-nerve, or single-feature OCT add value.
One study eye was selected per participant independently of OPG status. The retrospective cohort included 182 participants (58 OPG-positive and 124 OPG-negative eyes). Six primary feature sets compared baseline and longitudinal macular OCT, with and without clinical/visual variables, plus clinical/visual variables alone and visual acuity (VA) alone. Paired macular versus optic-nerve analyses used 141 participants with at least two paired examination dates.
Baseline macular OCT achieved pooled out-of-fold area under the precision-recall curve (PR-AUC) 0.819 and area under the receiver operating characteristic curve (ROC-AUC) 0.870, versus 0.551 and 0.667 for VA alone. Longitudinal summaries and added clinical/visual variables provided no clear gain. Baseline macular and optic-nerve OCT showed similar discrimination in the paired cohort (PR-AUC 0.787 vs. 0.802). Macular ganglion cell complex (GCL++) alone achieved PR-AUC 0.819 and ROC-AUC 0.844. Of 58 OPG-positive eyes, 31 (53.4%) had preserved baseline VA; among participants with preserved VA, baseline macular OCT retained discrimination (PR-AUC 0.701; ROC-AUC 0.831).
Macular OCT provided structural information beyond VA and showed similar discrimination to optic-nerve OCT. Longitudinal summaries offered no clear gain over baseline OCT, while GCL++ alone showed strong discrimination.
Simple macular OCT measures may complement clinical assessment and MRI surveillance but require external validation before clinical use.
PMID:
43055549
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0